UnitedHealth Group (NYSE:UNH) Stock Price Down 2.2% - What's Next?

Key Points

• UnitedHealth Group shares fell 2.2% to about $269.62 on Monday with volume slightly above average, and the stock remains below both its 50‑day ($297.19) and 200‑day ($324.39) moving averages.
• Wall Street sentiment is mixed but leans positive — the consensus rating is "Moderate Buy" with an average price target of $372.13, though several analysts have trimmed targets recently.
• The company slightly beat quarterly EPS and revenue expectations, set FY2026 guidance near 17.75 EPS, and pays a quarterly dividend that annualizes to $8.84 for a current yield of 3.3% (payout ratio ~67%).

UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report) fell 2.2% during mid-day trading on Monday . The stock traded as low as $269.09 and last traded at $269.6150. 10,208,455 shares changed hands during mid-day trading, an increase of 2% from the average session volume of 10,011,376 shares. The stock had previously closed at $275.59.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Zacks contrasts UnitedHealth’s consistent execution and diversified revenue mix favorably against peers, arguing UNH’s stability supports longer-term upside versus riskier turnarounds. The Upside Debate: UnitedHealth's Consistency vs. Centene's Comeback
• Positive Sentiment: Seeking Alpha argues market fears about UNH are overblown and that current volatility presents a buying opportunity given the company’s fundamentals and predictable cash flows. UnitedHealth Group: Fears Remain Overblown In A Panicky Market
• Neutral Sentiment: Industry pieces on value-stock rotation note that large, lower-valuation healthcare names could benefit as investors shift away from growth — a backdrop that could eventually help UNH if the rotation continues. 3 Value Stocks Set to Surge, With Up to 100% Upside by 2028
• Neutral Sentiment: Zacks education pieces flag medical stocks that could beat earnings; generalized upside signals for healthcare names but not a direct catalyst unless UNH is named in the specific beat candidates. These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
• Neutral Sentiment: The Motley Fool piece recommends two healthcare picks for long-term investors; it reinforces buy-and-hold narratives for the sector but offers no immediate UNH-specific catalyst. Have $500? 2 Healthcare Stocks Long-Term Investors Should Buy Right Now
• Negative Sentiment: Analyst research from Zacks (reported via American Banking News) issued a pessimistic earnings estimate for UNH, citing downside pressure on near-term EPS expectations. This type of note can trigger selling and analyst revisions. Zacks Research Issues Pessimistic Estimate for UNH Earnings
• Negative Sentiment: A separate report notes an analyst trimmed Q4 EPS estimates for UnitedHealth, adding to short-term downward pressure as investors re-price near-term growth and margin assumptions. Q4 EPS Estimate for UnitedHealth Group Decreased by Analyst

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on UNH shares. Evercore upgraded UnitedHealth Group to a "strong-buy" rating in a report on Tuesday, January 6th. Truist Financial lowered their target price on shares of UnitedHealth Group from $410.00 to $370.00 and set a "buy" rating for the company in a research note on Monday, February 2nd. Piper Sandler reiterated an "overweight" rating on shares of UnitedHealth Group in a report on Tuesday, January 27th. Morgan Stanley reduced their target price on shares of UnitedHealth Group from $411.00 to $409.00 and set an "overweight" rating on the stock in a research report on Friday, January 23rd. Finally, Mizuho reduced their price objective on UnitedHealth Group from $430.00 to $350.00 and set an "outperform" rating on the stock in a report on Thursday, February 5th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and a consensus price target of $372.13.

UnitedHealth Group Trading Down 2.2%

The stock has a market capitalization of $244.72 billion, a P/E ratio of 20.44, a price-to-earnings-growth ratio of 1.27 and a beta of 0.41. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.72. The company has a 50-day moving average price of $297.19 and a 200 day moving average price of $324.39.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, beating analysts' consensus estimates of $2.09 by $0.02. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The business had revenue of $113.73 billion for the quarter, compared to analysts' expectations of $113.38 billion. During the same period last year, the business earned $6.81 EPS. The company's revenue was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 3.3%. The ex-dividend date of this dividend was Monday, March 9th. UnitedHealth Group's dividend payout ratio (DPR) is currently 67.02%.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Sarver Vrooman Wealth Advisors purchased a new position in UnitedHealth Group in the fourth quarter valued at $25,000. Beacon Financial Strategies CORP purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $26,000. Anfield Capital Management LLC raised its holdings in UnitedHealth Group by 220.0% in the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate's stock worth $26,000 after purchasing an additional 55 shares during the period. Joseph Group Capital Management acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $27,000. Finally, Nalls Sherbakoff Group LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at approximately $27,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.